These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 3470737)

  • 21. Binding of D-phenylalanine and D-tyrosine to carboxypeptidase A.
    Christianson DW; Mangani S; Shoham G; Lipscomb WN
    J Biol Chem; 1989 Aug; 264(22):12849-53. PubMed ID: 2568989
    [TBL] [Abstract][Full Text] [Related]  

  • 22. 3D structure of Sulfolobus solfataricus carboxypeptidase developed by molecular modeling is confirmed by site-directed mutagenesis and small angle X-ray scattering.
    Occhipinti E; Martelli PL; Spinozzi F; Corsi F; Formantici C; Molteni L; Amenitsch H; Mariani P; Tortora P; Casadio R
    Biophys J; 2003 Aug; 85(2):1165-75. PubMed ID: 12885660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Phosphonate analogues of carboxypeptidase A substrates are potent transition-state analogue inhibitors.
    Hanson JE; Kaplan AP; Bartlett PA
    Biochemistry; 1989 Jul; 28(15):6294-305. PubMed ID: 2790000
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gem-dialkyl succinic acids: a novel class of inhibitors for carboxypeptidases.
    Asante-Appiah E; Seetharaman J; Sicheri F; Yang DS; Chan WW
    Biochemistry; 1997 Jul; 36(29):8710-5. PubMed ID: 9220957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydrolysis of esters by carboxypeptidase A requires a penta-coordinate metal ion.
    Kuo LC; Makinen MW
    J Biol Chem; 1982 Jan; 257(1):24-7. PubMed ID: 6273427
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 2-Benzyl-3,4-iminobutanoic acid as inhibitor of carboxypeptidase A.
    Park JI; Kim DH
    Bioorg Med Chem Lett; 2001 Nov; 11(22):2967-70. PubMed ID: 11677137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanistically significant diastereoselection in the sulfoximine inhibition of carboxypeptidase A.
    Mock WL; Zhang JZ
    J Biol Chem; 1991 Apr; 266(10):6393-400. PubMed ID: 2007591
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Binding of ligands to the active site of carboxypeptidase A.
    Rees DC; Lipscomb WN
    Proc Natl Acad Sci U S A; 1981 Sep; 78(9):5455-9. PubMed ID: 6946483
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Structure of the potato inhibitor complex of carboxypeptidase A at 2.5-A resolution.
    Rees DC; Lipscomb WN
    Proc Natl Acad Sci U S A; 1980 Aug; 77(8):4633-7. PubMed ID: 6933511
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 3-Phosphonopropionic acids inhibit carboxypeptidase A as multisubstrate analogues or transition-state analogues.
    Grobelny D; Goli UB; Galardy RE
    Biochem J; 1985 Nov; 232(1):15-9. PubMed ID: 4084224
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structure of potato inhibitor complex of carboxypeptidase A at 5.5-A resolution.
    Rees DC; Lipscomb WN
    Proc Natl Acad Sci U S A; 1980 Jan; 77(1):277-80. PubMed ID: 6928619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The physical state dependence of carboxypeptidase Aalpha and Agamma kinetics.
    Spilburg CA; Bethune JL; Vallee BL
    Proc Natl Acad Sci U S A; 1974 Oct; 71(10):3922-6. PubMed ID: 4530272
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Crystal structure of carboxypeptidase A complexed with an inactivator in two crystal forms.
    Chai JJ; He C; Li M; Tang L; Luo M
    Protein Eng; 1998 Oct; 11(10):841-5. PubMed ID: 9862201
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Crystal structure of the complex between carboxypeptidase A and the biproduct analog inhibitor L-benzylsuccinate at 2.0 A resolution.
    Mangani S; Carloni P; Orioli P
    J Mol Biol; 1992 Jan; 223(2):573-8. PubMed ID: 1738164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Carboxypeptidase A mechanisms.
    Lipscomb WN
    Proc Natl Acad Sci U S A; 1980 Jul; 77(7):3875-8. PubMed ID: 6933442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Crystallographic studies on apocarboxypeptidase A and the complex with glycyl-L-tyrosine.
    Rees DC; Lipscomb WN
    Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7151-4. PubMed ID: 6580631
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystallographic studies of angiotensin converting enzyme inhibitors and analysis of preferred zinc coordination geometry.
    Hausin RJ; Codding PW
    J Med Chem; 1990 Jul; 33(7):1940-7. PubMed ID: 2362274
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Similarities between the conformation of arsanilazotyrosine 248 of carboxypeptidase A in the crystalline state and in solution.
    Quiocho FA; McMurray CH; Lipscomb WN
    Proc Natl Acad Sci U S A; 1972 Oct; 69(10):2850-4. PubMed ID: 4507609
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Carboxypeptidase A: mechanism of zinc inhibition.
    Larsen KS; Auld DS
    Biochemistry; 1989 Dec; 28(25):9620-5. PubMed ID: 2611251
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peptidic mechanism-based inactivators for carboxypeptidase A.
    Ghosh SS; Wu YQ; Mobashery S
    J Biol Chem; 1991 May; 266(14):8759-64. PubMed ID: 2026592
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.